#SPX1dte Sold to Open $SPX Nov 15th 3050/3025 put spreads for 1.75, IV 9.37%, SPX close 3087
Sold this after the bell. I was wrong about a rally today but still think we have higher to go before this peters out.
Expiring today: 3065/3046 put credit spread and 3110/3125 call debit spread, trades placed Friday for net credit of .40.
#earnings #closing ROKU
and another one -Nov. 6, sold a Dec. 20 105/115/180/185 iron condor for 1.51, bought today for .97, still have a Nov. 22 195/205 long call spread that was an upside hedge, bought for .27, not making much, but not losing.
$AAPL STO 12/20 240/250 BUPS at 1.30
Sue, what is your plan for TGT #suecollar trade?
With the earning coming up, puts are very expensive.
#earnings #closing DIS
Finally able to close an earnings trade
Nov. 7, sold a Dec. 20, 120/145 strangle for 1.51, bought today for 1.18.
Starter position this morning.
STO the Dec 13 318/322 CCS for 0.34 when the market opened lower.
You could do better now or move up a strike. At the time the short was at delta 15-16.
5 contracts so max risk around $1700 with commissions.
Will wait on adding put spread until a bigger pull back.
Plan is to add new positions each week and manage at 21 DTE or 50% profits, or big movement to the short strike whichever occurs first. If the short delta hits 30-32 would modify.
#Earnings Sold to close final $UVXY Jan 2020 20 puts for 4.75. Avg purchase price 1.85. Still holding long $VXX 20 puts.
Rolled Nov. 15, 30.50 call to Dec. 20, 31 call for .58. TWTR shares were assigned, cost basis is 33.11
#ShortCalls Rolled Nov 15 342.50 call to Nov 22 350 call for .63 credit. This is paired with a Jan2021 180 short put. Wouldn’t mind owning TSLA down there at 180.
#ShortPuts – First time in this one. Aggressive sale inside the expected move but at the 50ma.
Sold UDOW DEC 20 2019 105.0 Put @ 2.90
Two small caps have some binary events coming up, and I wanted to play them.
$ADMP – Adamis Pharmaceuticals has a delayed PDUFA response from FDA on a higher dose Naloxone injection. Supposed to come out Oct 31st, but has been delayed. Open interest on the $2.50 Calls for Dec 2019 and March 2020 are over 19,000 this morning, but going out all the way to June didn’t cost much. BTO 5x $2.50 Call 6/19/20 at $0.20 at $1.00 debit. Price target for next few months would be $3-4.00 on the stock with approval, expecting total loss/lottery ticket with a CRL or other bad news. Stock is trading at about $1.00 this morning.
$AGRX – Agile Therapeutics has a contraceptive patch Twirla, with a PDUFA date of Nov. 16th. They’ve had two previous CRLs in the past years on the patch, but an advisory committee met late October and overwhelmingly supported it due to a lack of similar products. BTO 1x $2.50 Call 6/19/20 at $0.90. Price target would be $4.00, I will keep this one into next year most likely regardless of outcome. Stock is at about $2.24 at time of post.
There’s a great website I use that summarizes upcoming Biotech/Pharma dates, pipelines, etc. if anyone is interested: https://www.biopharmcatalyst.com/
Disclaimer: I’ve only used free services on this site, like their FDA calendar and weekly watch lists. Never paid money for subscription services as I’ve seen mixed reviews online.
Bought the following on 11/6 in anticipation of BIDU earnings after hours same day:
1x 11/8 $120 Call, 1x 11/8 $125 Call, 2x 11/8 $130 Call at Debit of: $1.19.
BIDU failed to break some overhead resistance after hours, so I figured I’d get out with a small win– sold all positions for $1.72 about an hour after open on Thursday– should’ve hung on a bit more as the stock blasted about $6 higher during midday trading and my $120 Call would’ve been closer to $4.85 or so by itself. That’s one thing I love about options trading as you get lessons everyday!
Took a position in $DERM for earnings on 11/5 (stock around $6.80 or so)- BTO 3x $8.00 Calls exp. 11/15 at $0.13. Stock didn’t pop too much after earnings, but their biggest competitor $ANAB failed on their Phase 2b. STC the same calls on Friday for $0.97 a piece, for a net profit of $252.00.